Statements (126)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:human_herpesvirus_8
gptkb:Herpes_simplex_virus gptkb:Kaposi's_sarcoma-associated_herpesvirus gptkb:cytomegalovirus |
| gptkbp:associated_with |
gptkb:healthcare_organization
chickenpox cytomegalovirus infection cold sores mononucleosis |
| gptkbp:caused_by |
gptkb:healthcare_organization
chickenpox shingles infectious mononucleosis cold sores cytomegalovirus disease herpes simplex virus infections mononucleosis |
| gptkbp:clinical_trial |
chronic infections
associated complications potential for reactivation widespread prevalence |
| gptkbp:communication |
direct contact
aerosol sexual contact airborne particles bodily fluids |
| gptkbp:complications |
pregnant women
newborns |
| gptkbp:contains |
gptkb:Human_herpesvirus_8
gptkb:Epstein-Barr_virus gptkb:Cytomegalovirus gptkb:Herpes_simplex_virus gptkb:Human_herpesvirus_6 gptkb:Human_herpesvirus_7 gptkb:Varicella-zoster_virus gptkb:Kaposi's_sarcoma-associated_herpesvirus |
| gptkbp:has_impact_on |
public health
|
| gptkbp:has_role |
vaccine development
|
| https://www.w3.org/2000/01/rdf-schema#label |
Herpesviridae
|
| gptkbp:is_associated_with |
immunocompromised individuals
chickenpox cancers cold sores mononucleosis |
| gptkbp:is_characterized_by |
double-stranded DNA
enveloped virus latent infection enveloped viruses |
| gptkbp:is_chronicled_in |
latent phase
lytic phase |
| gptkbp:is_divided_into |
gptkb:alpha_herpesviruses
gptkb:gamma_herpesviruses beta herpesviruses |
| gptkbp:is_essential_for |
public health
vaccine development antiviral drug research |
| gptkbp:is_found_in |
gptkb:Person
gptkb:mythological_figure |
| gptkbp:is_involved_in |
immunosuppression
immune evasion cellular transformation viral latency neurotropism |
| gptkbp:is_known_for |
immune evasion
latency in neurons recurrence of symptoms |
| gptkbp:is_linked_to |
chronic conditions
neurological disorders cancers |
| gptkbp:is_often_depicted_as |
developing countries
developed countries |
| gptkbp:is_protected_by |
vaccination
safe sex practices hygiene measures |
| gptkbp:is_recognized_by |
1880s
|
| gptkbp:is_studied_in |
gptkb:hospital
infectious diseases immunology virology |
| gptkbp:known_for |
latency in host cells
|
| gptkbp:lifespan |
latent phase
lytic phase |
| gptkbp:notable_members |
gptkb:KSHV
gptkb:EBV gptkb:HHV-6 gptkb:HHV-7 gptkb:HSV-1 gptkb:HSV-2 gptkb:VZV CMV |
| gptkbp:propagation_method |
direct contact
aerosol |
| gptkbp:publishes |
gptkb:physicist
|
| gptkbp:range |
gptkb:Person
gptkb:dog_breed cats primates |
| gptkbp:rank |
gptkb:family
|
| gptkbp:research_focus |
immune response
vaccine development pathogenesis antiviral drug resistance |
| gptkbp:scientific_classification |
gptkb:Beta_herpesvirinae
gptkb:Gamma_herpesvirinae Alpha herpesvirinae order Herpesvirales |
| gptkbp:seed_dispersal |
125-250 kb
|
| gptkbp:social_responsibility |
serological tests
PCR tests |
| gptkbp:subject |
genetic studies
public health initiatives clinical research epidemiological studies vaccine research therapeutic research pathogenesis research |
| gptkbp:subspecies |
gptkb:Gammaherpesvirinae
gptkb:Alphaherpesvirinae gptkb:Betaherpesvirinae |
| gptkbp:targets |
diagnostic tests
vaccine development antiviral therapies |
| gptkbp:treatment |
supportive care
antiviral medications |